ATE489998T1 - Biomaterialien in form von fasern zur verwendung als medizinprodukt bei der behandlung von wunden, und ihr herstellungsverfahren - Google Patents

Biomaterialien in form von fasern zur verwendung als medizinprodukt bei der behandlung von wunden, und ihr herstellungsverfahren

Info

Publication number
ATE489998T1
ATE489998T1 AT06754491T AT06754491T ATE489998T1 AT E489998 T1 ATE489998 T1 AT E489998T1 AT 06754491 T AT06754491 T AT 06754491T AT 06754491 T AT06754491 T AT 06754491T AT E489998 T1 ATE489998 T1 AT E489998T1
Authority
AT
Austria
Prior art keywords
biomaterials
wounds
treatment
fibers
medical device
Prior art date
Application number
AT06754491T
Other languages
English (en)
Inventor
Davide Bellini
Massimo Terrassan
Alessandra Pavesio
Original Assignee
Fidia Advanced Biopolymers Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Advanced Biopolymers Srl filed Critical Fidia Advanced Biopolymers Srl
Application granted granted Critical
Publication of ATE489998T1 publication Critical patent/ATE489998T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/225—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Surgery (AREA)
  • Dermatology (AREA)
  • Materials For Medical Uses (AREA)
AT06754491T 2005-07-07 2006-06-22 Biomaterialien in form von fasern zur verwendung als medizinprodukt bei der behandlung von wunden, und ihr herstellungsverfahren ATE489998T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000206A ITPD20050206A1 (it) 2005-07-07 2005-07-07 Biomateriali in forma di fibra da impiegarsi come dispositivi medici nel trattamento delle ferite e loro processi di produzione
PCT/EP2006/005992 WO2007006403A2 (en) 2005-07-07 2006-06-22 Biomaterials in the form of fibres for use as medical devices in the treatment of wounds, and their production process

Publications (1)

Publication Number Publication Date
ATE489998T1 true ATE489998T1 (de) 2010-12-15

Family

ID=36954719

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06754491T ATE489998T1 (de) 2005-07-07 2006-06-22 Biomaterialien in form von fasern zur verwendung als medizinprodukt bei der behandlung von wunden, und ihr herstellungsverfahren

Country Status (8)

Country Link
US (1) US20100144666A1 (de)
EP (1) EP1901786B1 (de)
AT (1) ATE489998T1 (de)
CA (1) CA2614212A1 (de)
DE (1) DE602006018611D1 (de)
IT (1) ITPD20050206A1 (de)
MX (1) MX2008000130A (de)
WO (1) WO2007006403A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8343942B2 (en) 2008-04-04 2013-01-01 University Of Utah Research Foundation Methods for treating interstitial cystitis
KR101594552B1 (ko) * 2008-04-04 2016-02-17 유니버시티 오브 유타 리서치 파운데이션 알킬화된 반합성 글리코사미노글리코산 에테르 및 이의 제조 및 사용 방법
CZ302503B6 (cs) 2009-12-11 2011-06-22 Contipro C A.S. Zpusob prípravy derivátu kyseliny hyaluronové oxidovaného v poloze 6 glukosaminové cásti polysacharidu selektivne na aldehyd a zpusob jeho modifikace
CZ302504B6 (cs) 2009-12-11 2011-06-22 Contipro C A.S. Derivát kyseliny hyaluronové oxidovaný v poloze 6 glukosaminové cásti polysacharidu selektivne na aldehyd, zpusob jeho prípravy a zpusob jeho modifikace
CZ302994B6 (cs) 2010-12-31 2012-02-08 Cpn S.R.O. Hyaluronová vlákna, zpusob jejich prípravy a použití
CA2830933A1 (en) 2011-03-23 2012-09-27 University Of Utah Research Foundation Methods for treating or preventing urological inflammation
CZ2012136A3 (cs) 2012-02-28 2013-06-05 Contipro Biotech S.R.O. Deriváty na bázi kyseliny hyaluronové schopné tvorit hydrogely, zpusob jejich prípravy, hydrogely na bázi techto derivátu, zpusob jejich prípravy a pouzití
CZ304512B6 (cs) 2012-08-08 2014-06-11 Contipro Biotech S.R.O. Derivát kyseliny hyaluronové, způsob jeho přípravy, způsob jeho modifikace a použití
CZ304654B6 (cs) 2012-11-27 2014-08-20 Contipro Biotech S.R.O. Nanomicelární kompozice na bázi C6-C18-acylovaného hyaluronanu, způsob přípravy C6-C18-acylovaného hyaluronanu, způsob přípravy nanomicelární kompozice a stabilizované nanomicelární kompozice a použití
CZ2012841A3 (cs) 2012-11-27 2014-02-19 Contipro Biotech S.R.O. Vlákna založená na hydrofobizovaném hyaluronanu, způsob jejich přípravy a použití, textilie na jejich bázi a použití
CZ305153B6 (cs) 2014-03-11 2015-05-20 Contipro Biotech S.R.O. Konjugáty oligomeru kyseliny hyaluronové nebo její soli, způsob jejich přípravy a použití
CZ2014451A3 (cs) 2014-06-30 2016-01-13 Contipro Pharma A.S. Protinádorová kompozice na bázi kyseliny hyaluronové a anorganických nanočástic, způsob její přípravy a použití
CZ309295B6 (cs) 2015-03-09 2022-08-10 Contipro A.S. Samonosný, biodegradabilní film na bázi hydrofobizované kyseliny hyaluronové, způsob jeho přípravy a použití
CZ306662B6 (cs) 2015-06-26 2017-04-26 Contipro A.S. Deriváty sulfatovaných polysacharidů, způsob jejich přípravy, způsob jejich modifikace a použití
CZ308106B6 (cs) 2016-06-27 2020-01-08 Contipro A.S. Nenasycené deriváty polysacharidů, způsob jejich přípravy a jejich použití
US11337994B2 (en) 2016-09-15 2022-05-24 University Of Utah Research Foundation In situ gelling compositions for the treatment or prevention of inflammation and tissue damage

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3482812D1 (de) 1983-10-11 1990-08-30 Fidia Spa Fraktionen von hyaluronsaeure mit pharmazeutischer aktivitaet, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen.
US4851521A (en) 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
IT1219587B (it) 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
EP0454358A3 (en) * 1990-04-23 1993-01-13 Merck & Co. Inc. Polysaccharide fibers
IT1254704B (it) 1991-12-18 1995-10-09 Mini Ricerca Scient Tecnolog Tessuto non tessuto essenzialmente costituito da derivati dell'acido ialuronico
IT1263393B (it) 1993-07-30 1996-08-05 Fidia Advanced Biopolymers Srl Processo per la preparazione e purificazione di acido ialuronico ad alto peso molecolare
ITPD940054A1 (it) * 1994-03-23 1995-09-23 Fidia Advanced Biopolymers Srl Polisaccaridi solfatati
US5390389A (en) 1994-05-16 1995-02-21 Emerson Electric Company Wheeled load carrier
IT1294797B1 (it) 1997-07-28 1999-04-15 Fidia Advanced Biopolymers Srl Uso dei derivati dell'acido ialuronico nella preparazione di biomateriali aventi attivita' emostatica fisica e tamponante
ITPD980169A1 (it) 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione.
IT1317359B1 (it) * 2000-08-31 2003-06-16 Fidia Advanced Biopolymers Srl Polisaccaridi percarbossilati, quali l'acido ialuronico, processo perla loro preparazione e loro impiego in campo farmaceutico e
US7262179B2 (en) * 2003-05-28 2007-08-28 Bristol-Myers Squibb Company Wound care compositions
ITPD20040245A1 (it) * 2004-10-08 2005-01-08 Fidia Advanced Biopolymers Srl Biomateriali costituiti da acido ialuronico solfatato e gellano utilizzabili nella prevenzione delle adesioni spinali

Also Published As

Publication number Publication date
US20100144666A1 (en) 2010-06-10
EP1901786B1 (de) 2010-12-01
ITPD20050206A1 (it) 2007-01-08
WO2007006403A3 (en) 2007-04-26
WO2007006403A2 (en) 2007-01-18
CA2614212A1 (en) 2007-01-18
MX2008000130A (es) 2008-03-11
DE602006018611D1 (de) 2011-01-13
EP1901786A2 (de) 2008-03-26

Similar Documents

Publication Publication Date Title
ATE489998T1 (de) Biomaterialien in form von fasern zur verwendung als medizinprodukt bei der behandlung von wunden, und ihr herstellungsverfahren
DE502006002836D1 (de) Verfahren zur herstellung von celluloseetherprodukten mit erhöhter viskosität und feinheit
ATE495739T1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
NO20080240L (no) Sammensetninger av delvis deacetylerte kitinderivater
DE502005010615D1 (de) Mittel zur behandlung von entzündlichen erkrankungen
WO2010123947A3 (en) Silk fibroin hydrogels and uses thereof
ATE543519T1 (de) Verwendung eines hämoglobins zur herstellung von verbänden und daraus resultierende verbände
EA201791669A3 (ru) Новые терапевтические подходы в лечении смт и связанных с ней расстройств
ATE502633T1 (de) Cyclosporins zur behandlung und vorbeugung von augenerkrankungen
EA201390826A1 (ru) ПИРИМИДИНОНОВЫЕ СОЕДИНЕНИЯ ДЛЯ ПРИМЕНЕНИЯ В ЛЕЧЕНИИ ЗАБОЛЕВАНИЙ ИЛИ СОСТОЯНИЙ, ОПОСРЕДОВАННЫХ Lp-PLA
ATE471977T1 (de) Vliesfaser für eine biomedizinische anwendung basierend auf poly(esteramid)en
ATE395905T1 (de) Pharmazeutische zusammensetzungen in form fester dispersionen zur behandlung von krebs
EA201290498A1 (ru) Терапевтические полимерные наночастицы, включающие эпотилон, и способы их получения и применения
TW200606162A (en) Pyrazolopyridine derivatives
BRPI0507680A (pt) partìculas de fosfato de cálcio terapêuticas e métodos de fabricação e uso das mesmas
DE602004014361D1 (de) Verwendung von oxazolidinon-chinolin-hybrid-antibiotika zur behandlung von anthrax und anderen infektionen
MX2009004467A (es) Compuestos benzoilo amino heterociclilo como activadores de la glucoquinasa (glk).
MY149505A (en) Hyaluronic acid binary mixtures and therapeutic use thereof
WO2008006204A8 (en) Fibrous calcium pyrophosphate particles and methods of making and using same
ATE549311T1 (de) Amino-propanolderivative als modulatoren des sphingosin-1-phosphat-rezeptors
EA200802020A1 (ru) Тетрагидропиримидоазепины и их применение в качестве модуляторов trpv 1
WO2009081408A3 (en) Pulverized fibrin clots and pharmaceutical compositions containing them
ATE452134T1 (de) Zur behandlung von auf eine modulation des dopamin-d3-rezeptors ansprechende erkrankungen geeignete 4-piperazinylpyrimidinverbindungen
EA201001408A1 (ru) Производные пиразинона как стимуляторы секреции инсулина, способы их получения и их применение для лечения диабетов
MA32416B1 (fr) 7-sulfanylmethyl-, 7-sulfinymethyl-et 7-sulfonylmethyl-indoles substitues et leur utilisation

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties